Let’s start up with the current stock price of Vaccinex Inc. (VCNX), which is $6.15 to be very precise. The Stock rose vividly during the last session to $5.65 after opening rate of $5.61 while the lowest price it went was recorded $5.27 before closing at $5.29.
Recently in News on September 17, 2020, Vaccinex Announces Clinical Collaboration with Merck to Evaluate Pepinemab in Combination with KEYTRUDA® in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a novel approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced that it has entered into a clinical collaboration agreement with Merck (known as MSD outside the US and Canada), through a subsidiary, to evaluate the combination of Vaccinex’s investigational SEMA4D inhibitor, pepinemab, and Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in the treatment of patients with advanced, recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). You can read further details here
Vaccinex Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $12.23 on 01/27/20, with the lowest value was $3.22 for the same time period, recorded on 06/25/20.
Vaccinex Inc. (VCNX) full year performance was -9.42%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Vaccinex Inc. shares are logging -49.71% during the 52-week period from high price, and 90.99% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.22 and $12.23.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5333343 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Vaccinex Inc. (VCNX) recorded performance in the market was 9.07%, having the revenues showcasing 51.14% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 106.59M, as it employees total of 45 workers.
The Analysts eye on Vaccinex Inc. (VCNX)
During the last month, 2 analysts gave the Vaccinex Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.74, with a change in the price was noted +2.07. In a similar fashion, Vaccinex Inc. posted a movement of +49.64% for the period of last 100 days, recording 441,171 in trading volumes.
Technical rundown of Vaccinex Inc. (VCNX)
Raw Stochastic average of Vaccinex Inc. in the period of last 50 days is set at 46.44%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 80.83%. In the last 20 days, the company’s Stochastic %K was 67.48% and its Stochastic %D was recorded 52.59%.
Considering, the past performance of Vaccinex Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 9.07%. Additionally, trading for the stock in the period of the last six months notably improved by 20.23%, alongside a downfall of -9.42% for the period of the last 12 months. The shares increased approximately by 1.73% in the 7-day charts and went up by -12.42% in the period of the last 30 days. Common stock shares were driven by 51.14% during last recorded quarter.